» Articles » PMID: 33050049

A Photocleavable Contrast Agent for Light-Responsive MRI

Overview
Publisher MDPI
Specialty Chemistry
Date 2020 Oct 14
PMID 33050049
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

Thanks to its innocuousness and high spatiotemporal resolution, light is used in several established and emerging applications in biomedicine. Among them is the modulation of magnetic resonance imaging (MRI) contrast agents' relaxivity with the aim to increase the sensitivity, selectivity and amount of functional information obtained from this outstanding whole-body medical imaging technique. This approach requires the development of molecular contrast agents that show high relaxivity and strongly pronounced photo-responsiveness. To this end, we report here the design and synthesis of a light-activated MRI contrast agent, together with its evaluation using UV-vis spectroscopy, Fast Field Cycling (FFC) relaxometry and relaxometric measurements on clinical MRI scanners. The high relaxivity of the reported agent changes substantially upon irradiation with light, showing a 17% decrease in relaxivity at 0.23T upon irradiation with λ = 400 nm (violet) light for 60 min. On clinical MRI scanners (1.5T and 3.0T), irradiation leads to a decrease in relaxivity of 9% and 19% after 3 and 60 min, respectively. The molecular design presents an important blueprint for the development of light-activatable MRI contrast agents.

Citing Articles

The Development of a Smart Magnetic Resonance Imaging and Chemical Exchange Saturation Transfer Contrast Agent for the Imaging of Sulfatase Activity.

Welleman I, ReeBing F, Boersma H, Dierckx R, Feringa B, Szymanski W Pharmaceuticals (Basel). 2023; 16(10).

PMID: 37895910 PMC: 10610007. DOI: 10.3390/ph16101439.


Mapping light distribution in tissue by using MRI-detectable photosensitive liposomes.

Simon J, Schwalm M, Morstein J, Trauner D, Jasanoff A Nat Biomed Eng. 2022; 7(3):313-322.

PMID: 36550300 PMC: 11232483. DOI: 10.1038/s41551-022-00982-3.

References
1.
Sadikot R, Blackwell T . Bioluminescence imaging. Proc Am Thorac Soc. 2005; 2(6):537-40, 511-2. PMC: 2713342. DOI: 10.1513/pats.200507-067DS. View

2.
Reessing F, Szymanski W . Beyond Photodynamic Therapy: Light-Activated Cancer Chemotherapy. Curr Med Chem. 2016; 24(42):4905-4950. DOI: 10.2174/0929867323666160906103223. View

3.
Slanina T, Shrestha P, Palao E, Kand D, Peterson J, Dutton A . In Search of the Perfect Photocage: Structure-Reactivity Relationships in meso-Methyl BODIPY Photoremovable Protecting Groups. J Am Chem Soc. 2017; 139(42):15168-15175. DOI: 10.1021/jacs.7b08532. View

4.
Solomek T, Mercier S, Bally T, Bochet C . Photolysis of ortho-nitrobenzylic derivatives: the importance of the leaving group. Photochem Photobiol Sci. 2012; 11(3):548-55. DOI: 10.1039/c1pp05308f. View

5.
Steinberg I, Huland D, Vermesh O, Frostig H, Tummers W, Gambhir S . Photoacoustic clinical imaging. Photoacoustics. 2019; 14:77-98. PMC: 6595011. DOI: 10.1016/j.pacs.2019.05.001. View